Measures Relevant to Cardiology
ID: 005NQF: 0081eMeasure ID: CMS135v9
2021 MIPS Measure #005: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
ID: 006NQF: 0067eMeasure ID:
2021 MIPS Measure #006: Coronary Artery Disease (CAD): Antiplatelet Therapy
ID: 007NQF: 0070eMeasure ID: CMS145v9
2021 MIPS Measure #007: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)
ID: 008NQF: 0083eMeasure ID: CMS144v9
2021 MIPS Measure #008: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
ID: 047NQF: 0326eMeasure ID:High Priority: Yes
2021 MIPS Measure #047: Advance Care Plan
ID: 110NQF: 0041eMeasure ID: CMS147v10
2021 MIPS Measure #110: Preventive Care and Screening: Influenza Immunization
ID: 111NQF: 0043eMeasure ID: CMS127v9
2021 MIPS Measure #111: Pneumococcal Vaccination Status for Older Adults
ID: 118NQF: 0066eMeasure ID:
2021 MIPS Measure #118: Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)
ID: 128NQF: 0421eMeasure ID: CMS69v9
2021 MIPS Measure #128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
ID: 130NQF: 0419eeMeasure ID: CMS68v10High Priority: Yes
2021 MIPS Measure #130: Documentation of Current Medications in the Medical Record
ID: 226NQF: 0028eMeasure ID: CMS138v9
2021 MIPS Measure #226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
ID: 236NQF: 0018eMeasure ID: CMS165v9High Priority: Yes
2021 MIPS Measure #236: Controlling High Blood Pressure
ID: 238NQF: 0022eMeasure ID: CMS156v9High Priority: Yes
2021 MIPS Measure #238: Use of High-Risk Medications in the Elderly
ID: 243NQF: 0643eMeasure ID:High Priority: Yes
2021 MIPS Measure #243: Cardiac Rehabilitation Patient Referral from an Outpatient Setting
ID: 317NQF:eMeasure ID: CMS22v9
2021 MIPS Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
ID: 322NQF:eMeasure ID:High Priority: Yes
2021 MIPS Measure #322: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria:Preoperative Evaluation in Low-Risk Surgery Patients
ID: 323NQF:eMeasure ID:High Priority: Yes
2021 MIPS Measure #323: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)
ID: 324NQF:eMeasure ID:High Priority: Yes
2021 MIPS Measure #324: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients
ID: 326NQF: 1525eMeasure ID:
2021 MIPS Measure #326: Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
ID: 344NQF:eMeasure ID:High Priority: Yes
2021 MIPS Measure #344: : Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)
ID: 374NQF:eMeasure ID: CMS50v9High Priority: Yes
2021 MIPS Measure #374: Closing the Referral Loop: Receipt of Specialist Report
ID: 402NQF: 2803eMeasure ID:
2021 MIPS Measure #402: Tobacco Use and Help with Quitting Among Adolescents
ID: 431NQF: 2152eMeasure ID:
2021 MIPS Measure #431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
ID: 438NQF:eMeasure ID: CMS347v4
2021 MIPS Measure #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
ID: 441NQF:eMeasure ID:High Priority: Yes
2021 MIPS Measure #441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)